Skip to main content
Figure 2 | Breast Cancer Research

Figure 2

From: Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67

Figure 2

Overall survival of patients with triple-negative breast cancer according to receipt of adjuvant therapy. (A) Patients who underwent surgery plus adjuvant therapy showed a better prognosis than those who underwent surgery alone (P = 0.0043). (B) Prognosis of patients according to the clinical stage. Overall survival of patients by adjuvant chemotherapy was significantly better at Stage II (P = 0.0013).

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us